We would love to hear your thoughts about our site and services, please take our survey here.
Rorkes, I think its just lost in translation a bit.
It's a 90% dose (not high) but potentially a high concentration in the tumour, which COULD be the equivalent of a high dose.
At least I think thats what is being suggested.
Curius - I don't think thats how he works.
He talks up stocks he's in and looking for higher returns (understandably), and goes quiet when selling. He seems more straight than many of the stock commentators.
There are plenty of people who invested here much higher and will sell based on emotion, rather than future prospects/growth.
Disgruntled makes a fair point.
The share sales met their tax obligations "in part", which I assume means they sold more than they needed to, to meet those obligations.
Its not a good look, especially when most of the directors sold shares at 17-19p in February.
Theres a lot of useless noise on this board lately.
Yes the SP drop is horrible, but if you knew what you were doing, you invested here because Avacta is a lot more than just an LFT company. The big short term LFT payday appears to have gone, but the long term prospects are alive and kicking, and fully funded up to and beyond critical research timelines/results. Thats an enviable position for a company like this to be in.
So if you can, sit back, relax, and wait for the SP rollercoaster to move back up to fair value over the coming months and years.
Wyn, I don't think another 10-20 million vaccinations of younger healthier people will achieve anything, other than prevent health workers caring for sick people, because they are too busy vaccinating those who don't need a vaccine.
I know if we have more people suffering with covid and extended lockdowns we make more money here, but this fearmongering is ridiculous.
The numbers of people dying from covid are tiny. We have more suicides every day, mainly in younger people, but nobody cares about continuing to damage young people's lives with these restrictions.
Covid is a seasonal virus - it will be subdued in the summer months, before going up in the winter and cause deaths in the elderly and vulnerable - just as flu always did, which never used to bother us.
Yes, covid is worse, but the vaccines change that. Also, viruses typically become less virulent over time when they mutate (you won't hear that from the mainstream media or government). They just say every new variant is 50% ish more infectious, which if you do the maths, we're supposed to now have a massively more transmissable virus than the first and 2nd waves, whilst the numbers have dwindled to almost nothing - and people sill believe this rubbish, FFS!
I'm all for making money here on the help that Avacta's LFT can bring, but the fearmongering and the welcoming of ongoing restrictions just does my head in.
Rant over!
The longer this drags on, the more inclined I am to think that MHRA registration has been confirmed and that the test is already ("immediately") on the market.
An RNS confirming registration but with a delay in commercials could actually drive the SP down, as our likely expectations when AL says immediately, is that Avacta will have deals already lined up and sell the tests immediately.
So perhaps AL would rather leave us speculating about how long "the coming days" is, rather than how long "immediately" is, and why haven't we sold anything yet.
Ophidian gave us a detailed timeline to expect a test ready last september, following a simple, 2-week tech transfer. He then went on to say that tech transfer was complete in november (because he couldn't understand the RNS).
He is an expert in telling everybody he's an expert, and there his expertise ends!
And predicting an RNS to land today, tomorrow or in the coming days requires zero expertise.
Taking Avacta out of the equation, the odd thing about this 9+ working days wait, is that the government were desperate to deliver 'operation moonshot' last year, and now they can't be bothered to rubber stamp a great UK developed test.
So the longer this goes on, the less it becomes about AL's ability to communicate timelines, and more about why the hell the UK authorities are delaying approval.
I have no theories on why they are dragging their feet, just frustrations and growing concern on why it hasn't happened yet.
Lets hope tomorrow morning the wait becomes irrelevant / worth it.
When the CE marking arrives, we'll find out how long "in the coming days" is.
But what are the odds that the commercials are not announced at the same time, and then we'll be speculating how long "immediately" is in 'Avacta time' ;-)
I may or may not have missed if the dispute with the government over the antibody test has been resolved, but I received one of the AbC-19 tests today from UK biobank today. . . . . so they are definitely using them, and therefore need to pay for them!
Avacta's understanding and communication of expected timelines id fu**ing incompetent!
In Feb and March we were repeatedly told to expect CE mark and commercials by or around the end of March. These weren't long term predictions - A 3-week prediction on 8th March for CE marking is now into its 9th week. That's pathetic!
The target dates were bumped on in April to early May, which at a stretch is today at the very latest and still nothing.
Am I selling? No. This is a good investment with great potential. But please, FFS, stop building up our hopes and expectations on timescales, only to fail, and fail, and fail again!
Rant over!
I can be sceptical of companies that seem to over-promote themselves, but I have to say that so far Tirupati have delivered everything they promised, and more! I Couldn't be more impressed.
If they continue to grow as set out, the SP will do great.
If this composite they've developed comes off, and it is still an if, then the rewards will be huge.
So I've increased my stake here, as it feels like the returns will be somewhere between very good, ..... and brilliant!
GLA.
i just double-checked the 8th March RNS which predicted full CE marking around the end of March.
So We're now in week 8 of a 3 week prediction!
This investment is great overall, but AL's timeline expectations are appalling and so frustrating!